IKI. V. Kuchin

I. V. Kuchin

*This is an algorithmically generated author record based on publicly available information.

I. V. Kuchin has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Transcatheter edge-to-edge mitral valve repair using G4 clips in the treatment of patients with central and noncentral severe primary mitral regurgitation

    by M.I. Makeev, M.A. Saidova, I.V. Kuchin, A.E. Komlev, T.E. Imaev

    Objective. To evaluate in-hospital outcomes in patients with central and noncentral severe primary mitral regurgitation (PMR) after transcatheter edge-to-edge mitral valve repair (TMVR). Material and methods. The study included 62 high risk patients with severe symptomatic PMR: group 1 — 45 (72.6%) patients with central mitral regurgitation (MR), group 2 — 17 (27.4%) patients with noncentral MR. Mean age was 75 [68; 83] years, and 58.1% of patients were men. MitraClip G4 devices were implanted. Left ventricular (LV) volumetric dimensions, ejection fraction, and central hemodynamic parameters were assessed using echocardiography at baseline and 4-5 days after intervention. A detailed quantitative analysis of MR was performed, and mean mitral valve pressure gradient was calculated. Results. In early postoperative period, MR significantly reduced in both groups (p<0.001). Technical success rate was comparable in both cohorts (95.6% in central MR and 82.4% in noncentral MR, p=0.12). Hemodynamic efficacy of TMVR was more obvious in the 1st group as evidenced left ventricular end-diastolic volume (LVEDV) and LV central hemodynamic parameters. LVEDV decreased in the first group from 140 [103; 161] to 113 [87; 140] ml (p<0.001), in the second group — from 118 [94; 170] to 110 [83; 166] ml (p=0.015). Chordae tendineae rupture did not affect technical success of TMVR, but was associated with implantation of two clips (p=0.03). The number of clips did not differ between patients with central (1.56) and noncentral (1.53) MR (p=0.88). TMVR increased mean mitral valve pressure gradient in both cohorts of patients. However, this parameter was similar in postoperative period in both groups with increased number of clips. Conclusion. Transcatheter edge-to-edge mitral valve repair using G4 clips is an effective correction of central and noncentral severe primary mitral regurgitation.

  • Heterotopic bicaval implantation of transcatheter system for the treatment of severe tricuspid regurgitation

    by T.E. Imaev, A.Z. Khulamkhanova, A.E. Komlev, M.A. Saidova, P.M. Lepilin, A.S. Kolegaev, I.V. Kuchin, D.V. Salichkin

    The authors describe the first case of heterotopic bicaval implantation of transcatheter valve system in Russia for correction of severe tricuspid regurgitation in a patient with extremely high surgical risk and contraindication for redo surgery under cardiopulmonary bypass. The patient did not meet anatomical criteria for transcatheter edge-to-edge tricuspid valve repair. This case demonstrates the effectiveness of heterotopic bicaval implantation for tricuspid valve disease in high-risk patient with better control of chronic heart failure and positive reverse right ventricular remodeling over a 12-month follow-up.

  • Open Access

    Prediction of Cardiovascular Events and Structural and Functional Remodeling of the Heart in Patients With Severe Mitral Regurgitation of Various Genesis Underwent Transcatheter Mitral Valve Repair “Edge-To-Edge”

    by M. I. Makeev, M. A. Saidova, A. A. Safiullina, A. E. Komlev, I. V. Kuchin, M. M. Kantemirova, T. E. Imaev

    Aim . To search for predictors of adverse cardiovascular events after edge-to-edge transcatheter mitral valve repair (TMVR) in patients with severe mitral regurgitation (MR) of various origins with an assessment of structural and functional remodeling of the heart and left ventricular (LV) contractile function. Material and methods. The study included 73 patients (median age 71 [63; 80] years, 60.3% men) at a high surgical risk with severe MR of primary and secondary genesis, who underwent TMVR. The second-generation (58.9%) and fourth-generation (41.1%) clips were implanted. In addition to standard echocardiographic (EchoCG) indices, the parameters of left heart chamber longitudinal strain and LV myocardial function were assessed at baseline, on days 4-5, and at 6 and 12 months after the intervention. Also, the N-terminal fragment of the pro-brain natriuretic peptide (NT-proBNP) was assessed at baseline and on days 4-5 after TMVR. Results . A significant decrease in MR was achieved during 12 months of follow-up. In the group with primary mitral regurgitation (PMR), MR decreased from 4.0 [3.4; 4.0] to 2.0 [1.5; 2.5] at one year of follow-up (pConclusion . Edge-to-edge TMVR exerts a positive effect on the prognosis and structural and functional remodeling of the heart in patients with PMR and SMR. Myocardial function indices may be useful in assessing the LV contractile function in patients with severe MR of various origins. Identification of predictors for adverse cardiovascular events, including with new EchoCG technologies, may contribute to better patient stratification.


  • Transcatheter aortic valve implantation in patients with bicuspid aortic valve

    by D.S. Mkrtychev, A.E. Komlev, A.S. Kolegaev, P.M. Lepilin, I.V. Kuchin, D.V. Salichkin, M.R. Kabardieva, T.E. Imaev

    Objective. To study in-hospital outcomes of transcatheter aortic valve implantation (TAVI) in patients with bicuspid aortic valve. Material and methods. The study included 83 patients who underwent TAVI with Medtronic and Boston Scientific self-expanding prostheses between June 2022 and June 2023. Patients were divided into groups depending on aortic valve nature: 28 patients in the main group and 55 patients in the control group. We recorded complications including perioperative and in-hospital mortality, cardiac arrhythmias and pacemaker implantation rate. Results. We obtained the results related to anatomical features of aortic valve and ascending aorta. Larger valves were more common in the main group, but there were no significant differences in postoperative parameters. Conclusion. Our study demonstrates effective and safe TAVI in appropriate patients with bicuspid valves whose results are not inferior to those for normal anatomy.

  • Left ventricular reverse remodeling after transcatheter mitral valve repair in a patient with ischemic cardiomyopathy

    by N.S. Maslennikova, M.I. Makeev, I.V. Kuchin, O.S. Bulkina, A.E. Komlev, O.F. Egorkina, E.V. Kozlova, V.V. Lopukhova, P.S. Laguta, T.E. Imaev, et al.

    Progressive left ventricular systolic dysfunction following secondary mitral regurgitation leads to global myocardial dyssynchrony. This process is associated with severe chronic heart failure and higher risk of sudden cardiac death. In addition to optimal drug therapy, these patients require cardiac resynchronization therapy, cardiac contractility modulation, as well as surgical correction of mitral insufficiency. We present a patient with severe chronic heart failure due to ischemic cardiomyopathy, severe mitral insufficiency, cardiac arrhythmia and conduction disorders. Reverse myocardial remodeling and clinical improvement transcatheter mitral valve repair throughout a year.

  • Open Access

    Transcatheter aortic valve implantation with commissural alignment

    by D. V. Salichkin, A. E. Komlev, P. M. Lepilin, A. S. Kolegaev, I. V. Kuchin, A. A. Nurkhametova, T. E. Imaev

    Transcatheter aortic valve implantation (TAVI) is commonly accepted method of treatment of aortic stenosis in most patients with currently increasing number of TAVI procedures. Patients after TAVI frequently have indications for percutaneous coronary intervention (PCI) that might be technically challenging due to the presence of transcatheter valve. Compromising coronary ostia involves such issues as design of the prosthesis and its position in the aortic root with respect to the commissures of native aortic valve. Since TAVI with commissural alignment can mitigate risk of compromising coronary ostia, this option should be considered while planning TAVI, especially in younger patients with coronary atherosclerosis and relatively high probability of PCI in the future. The algorithm of commissural alignment in clinical practice of TAVI up to date has been proposed only for several transcatheter heart valves reported in this paper.

  • Transcatheter edge-to-edge mitral valve repair in patients with severe mitral regurgitation. (The first Russian experience of one-year follow-up)

    by M.A. Saidova, M.I. Makeev, I.V. Kuchin, A.E. Komlev, T.E. Imaev, R.S. Akchurin

    ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить результаты транскатетерной пластики митрального клапана (МК) по типу «край-в-край» у пациентов высокого хирургического риска с дегенеративной и функциональной митральной недостаточностью в раннем и отдаленном периодах наблюдения. МАТЕРИАЛ И МЕТОДЫ С 2020 по 2021 г. проспективно в исследование включено 43 пациента, медиана возраста составила 73 года [64; 82], 23 пациента с вторичной митральной недостаточностью (ВМН), 20 пациентов с первичной митральной недостаточностью (ПМН). Проводилась транскатетерная пластика МК методом «край-в-край» с имплантацией клипс второго поколения. Всем пациентам выполнялись трансторакальная и чреспищеводная эхокардиография исходно, через 4—5 дней, 6 и 12 мес после вмешательства с детальной оценкой количественных параметров митральной регургитации, показателей ремоделирования и центральной гемодинамики левого желудочка. РЕЗУЛЬТАТЫ Непосредственный технический успех операции определялся в 95% случаев. Госпитальная летальность произошла в 1 случае, общая летальность при медиане наблюдения 16 мес — у 7 (16,3%) пациентов, госпитализация в течение 1 года по поводу сердечно-сосудистых событий — у 11 (25,6%) пациентов. На фоне проводимого вмешательства к 12 мес наблюдения отмечалось достоверное снижение степени митральной недостаточности в обоих когортах пациентов: ПМН (с 3,7±0,54 до 2,4±0,68; p=0,039), ВМН (с 3,3±0,45 до 2,2±0,56; p0,05; объем ЛП с 136 [114; 154] до 123 [110; 148] мл, p>0,05. ЗАКЛЮЧЕНИЕ Представленные данные демонстрируют результат эффективного способа коррекции тяжелой митральной недостаточности различного генеза у пациентов высокого хирургического риска, сохраняющегося на протяжении 12 мес наблюдения.


  • Atrial septal defect closure after transcatheter mitral valve repair with the MitraClip NT system

    by I.V. Kuchin, D.V. Salichkin, A.E. Komlev, M.I. Makeev, D.S. Mkrtychev, S.M. Smirnov, M.R. Kabardieva, T.E. Imaev, M.A. Saidova

    The authors report mitral transcatheter edge-to-edge repair in a patient with severe degenerative mitral insufficiency complicated by severe bypass through the iatrogenic atrial septal defect in delayed postoperative period. Subsequently, the patient underwent successful minimally invasive atrial septal defect closure with favorable clinical result.

  • Open Access

    Transcatheter mitral valve edge-to-edge repair in patients with severe mitral regurgitation: data from the MitraClip Russia Trial

    by T. E. Imaev, A. E. Komlev, I. V. Kuchin, M. A. Saidova, A. S. Kolegaev, M. I. Makeev, D. V. Salichkin, P. M. Lepilin, A. A. Margolina, S. A. Boytsov, et al.

    Aim. To study the immediate and short-term outcomes of transcatheter mitral valve edge-to-edge repair with the MitraClip NT in patients with severe mitral regurgitation as part of the MitraClip Russia prospective single-center study.Material and methods. The study included 16 patients (men, 10; women, 6) with mean age of 70,1±2,1 years (mean Euroscore II, 6,90±5,56%; STS, 6,33±3,94%). Immediate technical success was defined as successful access, delivery, and removal of the device, and adequate placing the clip(s) to reduce the mitral regurgitation to grade 2 or below without the need for device- or procedure-related reintervention.Results. Immediate technical success was achieved in all patients. The average number of implanted clips per 1 patient was 1,7. In 1 patient (6,3%), a clip was attached to one mitral leaflet, which required an non-scheduled implantation of a second clip. In hospital mortality was 6,3%: a 92-year-old patient on the 3rd day after the operation had a sudden cardiac arrest followed by coma, hemispheric ischemic stroke and death on the 6th day. An autopsy revealed an iatrogenic atrial septal defect. Echocardiography performed on the 10th and 30th day after surgery showed a decrease in mitral regurgitation grade in 15 patients, while grade 3 residual mitral regurgitation did not reveal in any patient.Conclusion. Transcatheter mitral valve edge-to-edge repair with the MitraClip is a minimally invasive method for treating severe symptomatic mitral regurgitation (degenerative and functional). The results demonstrate high immediate efficacy and an acceptable safety profile in high surgical risk patients. Based on the analysis of death causes, the authors conclude that it is necessary to include initial pulmonary hypertension above 75 mm Hg as a relative contraindication to this procedure. The study limitations are the small sample size and short follow-up period.


  • Takotsubo syndrome and interatrial septum rupture — a rare combination of complications after transcatheter mitral valve repair

    by A.E. Komlev, K.G. Ganaev, T.E. Imaev, M.A. Saidova, I.V. Kuchin, M.I. Makeev, E.V. Kurilina, R.S. Akchurin

    Транскатетерные методы лечения тяжелой митральной регургитации, прежде всего, краевая пластика створок митрального клапана, эффективно используется у пациентов высокого хирургического риска, однако несмотря на высокий профиль безопасности, данная процедура не лишена специфических осложнений. Представляем уникальное наблюдение летального исхода после транскатетерной пластики митрального клапана системой MitraClip, осложненное разрывом межпредсердной перегородки и синдромом Такоцубо. Центральным звеном патогенеза явилась высокая легочная гипертензия, тотальному внутрисердечному шунтированию крови справа налево через ятрогенный дефект межпредсердной перегородки. В статье рассматриваются трудности диагностики редкой комбинации осложнений транскатетерного лечения митральной регургитации и обсуждаются особенности отбора пациентов для проведения данного вмешательства.